1/11
07:40 pm
amlx
Amylyx Pharmaceuticals (AMLX) Valuation Check As New GLP-1 Candidate AMX0318 Enters Development Stage [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals (AMLX) Valuation Check As New GLP-1 Candidate AMX0318 Enters Development Stage [Yahoo! Finance]
1/10
03:11 pm
amlx
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases [Yahoo! Finance]
1/8
07:00 am
amlx
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
Medium
Report
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
12/20
01:30 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) was downgraded by analysts at
Wall
Medium
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) was downgraded by analysts at
Wall
12/9
06:29 pm
amlx
Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
Low
Report
Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
12/5
09:00 am
amlx
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
Medium
Report
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
11/28
06:40 pm
amlx
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Medium
Report
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
11/13
02:40 pm
amlx
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
Low
Report
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
11/11
06:00 pm
amlx
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
Medium
Report
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
11/10
05:38 am
amlx
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After a Sharp Rally and Recent Pullback [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After a Sharp Rally and Recent Pullback [Yahoo! Finance]
11/7
03:01 pm
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $16.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $16.00 to $20.00. They now have a "buy" rating on the stock.
11/6
10:28 am
amlx
Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf
Low
Report
Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf
11/6
07:00 am
amlx
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
High
Report
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
11/3
09:00 am
amlx
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences
Low
Report
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences
10/30
09:20 am
amlx
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf
Low
Report
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf
10/30
09:00 am
amlx
Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
Low
Report
Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
10/28
06:18 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Low
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
10/27
12:20 pm
amlx
Halper Sadeh LLC Encourages Amylyx Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages Amylyx Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
10/26
06:31 am
amlx
BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet [Yahoo! Finance]
Low
Report
BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet [Yahoo! Finance]
10/24
08:10 pm
amlx
What Makes Amylyx Pharmaceuticals, Inc. (AMLX) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Low
Report
What Makes Amylyx Pharmaceuticals, Inc. (AMLX) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
10/22
10:13 am
amlx
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm